K K W Chan - JoVE Visualize

Showing results (1-10 of 24) with videos related to

Pageof 3

Sort By:

Techniques in Coloproctology|October 20, 2012

External haemorrhoidal thrombosis: evidence for current managementK K W Chan, J D R Arthur

Current Oncology (Toronto, Ont.)|December 11, 2019

Metastatic colorectal cancer: therapeutic options for treating refractory diseaseA Parmar, K K W Chan, Y J Ko

Current Oncology (Toronto, Ont.)|June 23, 2016

Provincial elections and timing of cancer drug fundingA Srikanthan, S S Gill, K K W Chan

Current Oncology (Toronto, Ont.)|December 23, 2017

A systematic review and network meta-analysis of post-imatinib therapy in advanced gastrointestinal stromal tumourK Shah, K K W Chan, Y J Ko

Journal of Viral Hepatitis|March 14, 2015

Hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients receiving rituximab for lymphoma: a meta-analysisL Mozessohn, K K W Chan, J J Feld, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 30, 2015

Interpreting febrile neutropenia rates from randomized, controlled trials for consideration of primary prophylaxis in the real world: a systematic review and meta-analysisJ Truong, E K Lee, M E Trudeau, et al.

Current Oncology (Toronto, Ont.)|August 17, 2018

Understanding the reasons for provincial discordance in cancer drug funding-a survey of policymakersA Srikanthan, N Penner, K K W Chan, et al.

Leukemia & Lymphoma|January 14, 2016

Granulocyte colony-stimulating factor in secondary prophylaxis for advanced-stage Hodgkin lymphoma treated with ABVD chemotherapy: a cost-effectiveness analysisM C Cheung, A Prica, J Graczyk, et al.

Current Oncology (Toronto, Ont.)|May 12, 2017

Systemic therapy in the curative treatment of head-and-neck squamous cell cancer: Cancer Care Ontario clinical practice guidelineE Winquist, C Agbassi, B M Meyers, et al.

Current Oncology (Toronto, Ont.)|September 9, 2020

A cost-utility analysis of atezolizumab in the second-line treatment of patients with metastatic bladder cancerA Parmar, M Richardson, P C Coyte, et al.

Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:

Pageof 3

Techniques in Coloproctology|October 20, 2012

External haemorrhoidal thrombosis: evidence for current managementK K W Chan, J D R Arthur

Current Oncology (Toronto, Ont.)|December 11, 2019

Metastatic colorectal cancer: therapeutic options for treating refractory diseaseA Parmar, K K W Chan, Y J Ko

Current Oncology (Toronto, Ont.)|June 23, 2016

Provincial elections and timing of cancer drug fundingA Srikanthan, S S Gill, K K W Chan

Current Oncology (Toronto, Ont.)|December 23, 2017

A systematic review and network meta-analysis of post-imatinib therapy in advanced gastrointestinal stromal tumourK Shah, K K W Chan, Y J Ko

Journal of Viral Hepatitis|March 14, 2015

Hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients receiving rituximab for lymphoma: a meta-analysisL Mozessohn, K K W Chan, J J Feld, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 30, 2015

Interpreting febrile neutropenia rates from randomized, controlled trials for consideration of primary prophylaxis in the real world: a systematic review and meta-analysisJ Truong, E K Lee, M E Trudeau, et al.

Current Oncology (Toronto, Ont.)|August 17, 2018

Understanding the reasons for provincial discordance in cancer drug funding-a survey of policymakersA Srikanthan, N Penner, K K W Chan, et al.

Leukemia & Lymphoma|January 14, 2016

Granulocyte colony-stimulating factor in secondary prophylaxis for advanced-stage Hodgkin lymphoma treated with ABVD chemotherapy: a cost-effectiveness analysisM C Cheung, A Prica, J Graczyk, et al.

Current Oncology (Toronto, Ont.)|May 12, 2017

Systemic therapy in the curative treatment of head-and-neck squamous cell cancer: Cancer Care Ontario clinical practice guidelineE Winquist, C Agbassi, B M Meyers, et al.

Current Oncology (Toronto, Ont.)|September 9, 2020

A cost-utility analysis of atezolizumab in the second-line treatment of patients with metastatic bladder cancerA Parmar, M Richardson, P C Coyte, et al.

Pageof 3